The role of transcription factors in erythroid development

Annals of Medicine

Volumn 28, Issue 1, 1996, Pages 47-55

  Bungert, Jörg ^a   Engel, James Douglas ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Erythroid; Transcription factors

Indexed keywords

DNA BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ERYTHROID CELL; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; REVIEW;

EID: 0030021745     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999074     Document Type: Review

References (60)

1. Tjian R, Maniatis T. Transcriptional activation: a complex puzzle with few easy pieces. Cell 1994; 77: 5-8.
2. Ness SA, Engel JD. Vintage reds and whites: combinatorial transcription factor utilization in hematopoietic differentiation. Curr Opin Genet Dev 1994; 4: 718-24.
3. Felsenfeld G. Chromatin as an essential part of the transcriptional mechanism. Nature 1992; 355: 219-24.
4. Schmeichel KL, Beckerle MC. The LIM domain is a modular protein-binding interface. Cell 1994; 79: 211-9.
5. Stamatoyannopoulos G, Neinhuis AW. Hemoglobin switching. In: Stamatoyannopoulos G, Nienhuis AW, Majerus P, Varmus H, eds. The Molecular Basis of Blood Diseases, 2nd edn. New York: WB Saunders Co, 1994: 107-55.
6. Engel JD. Developmental regulation of human β-globin gene transcription: a switch of loyalties? Trends Genet 1993; 9: 304-9.
7. Forrester WC, Takegawa S, Papayannopoulou T, Stammatoyannopoulos G, Groudine M. Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res 1987; 15: 10159-77.
8. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell 1987; 51: 975-85.
9. Thomas KR, Capecchl MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51: 503-12.
10. Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, Engel JD. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev 1990; 4: 1650-62.
11. Ko LJ, Engel JD. DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol 1993; 13: 4011-22.
12. Merika M, Orkin SH. DNA-binding specificity of GATA family transcription factors. Mol Cell Biol 1993; 13: 3999-4010.
13. Tsai S-F, Martin DIK, Zon LI, D'Andrea AD, Wong GG SH, Orkin SH. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 1989; 339: 446-51.
14. Evans T, Felsenfeld G. The erythroid-specific transcription factor Eryf1: a new finger protein. Cell 1989; 58: 877-85.
15. Romeo P-H, Prandinl M-H, Joulin V, et al. Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature 1990; 344: 447-9.
16. Martin DIK, Zon LI, Mutter G, Orkin SH. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature 1990; 344: 444-7.
17. Ito E, Toki T, Ishihara H, et al. Erythroid transcription factor GATA-1 is abundantly transcribed in mouse testis. Nature 1993; 362: 466-9.
18. Berry M, Grosveld F, Dillon N. A single point mutation is the cause of the Greek form of hereditary persistence of fetal hemoglobin. Nature 1992; 358: 499-502.
19. Raich N, Clegg CH, Grofti J, Romeo P-H, Stamatoyannopoulos G. GATA1 and YY1 are developmental repressors of the human c-globin gene. EMBO J 1995; 14: 801-9.
20. Merika M, Orkin SH. Functional synergy and physical interactions of the erythroid transcription factor QATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol Cell Biol 1995; 15: 2437-47.
21. Pevny L, Simon MC, Robertson E, et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991; 349: 257-60.
22. Simon MC, Pevny L, Wiles MV, Keller G, Costantini F, Orkin SH. Rescue of erythroid development in gene targeted GATA-1-mouse embryonic stem cells. Nat Genet 1992; 1: 92-8.
23. Zon LI, Youssoufian H, Mather C, Lodish HF, Orkin SH. Activation of the erythroprotein receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci USA 1991; 88: 10638-41.
24. Dorfman DM, Wilson DB, Bruns GAP, Orkin SH. Human transcription factor GATA-2; evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 1992; 267: 1279-85.
25. Nagai T, Harigae H, Ishihara H, et al. Transcription factor GATA-2 is expressed in erythroid, early myeloid and CD34+ human leukemia-derived cell lines. Blood 1994; 84: 1074-84.
26. Tsai F-Y, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 1994; 371: 221-6.
27. Briegel K, Lim K-C, Plank C, Beug H, Engel JD, Zenke M. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev 1993; 7: 1097-109.
28. Weiss MJ, Keller G, Orkin SH. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1-embryonic stem cells. Genes Dev 1994; 8: 1184-97.
29. Zon LI, Gurish MF, Stevens RL, et al. GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. J Biol Chem 1991; 266: 22948-53.
30. Leonard MW, Lim K-C, Engel JD. Expression of the GATA transcription factor family during early erythroid development and differentiation. Development 1993; 119: 519-31.
31. Pandolfi PP, Roth ME, Karis A, et al. Targeted disruption of the GATA-3 gene causes severe abnormalities of the CNS, haemorrage and altered haematopoiesis. Nat Genet 1995; 11: 40-4.
32. Andrews NC, Erjument-Bromage H, Davidson MB, Tempst P, Orkin SH. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 1993; 362: 722-8.
33. Mignotte V, Eleouet JF, Raich N, Romeo P-H. Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc Natl Acad Sci USA 1989; 86: 6548-52.
34. Andrews NC, Kotkow KJ, Ney PA, Erdjument-Bromage H, Tempst. P, Orkin SH. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc Natl Acad Sci USA 1993; 90: 11488-92.
35. Igarashi K, Kataoka K, Itoh K, Hayashi N, Nishizawa M, Yamamoto M. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 1994; 367: 568-72.
36. Engel JD. Meticulous AP-1 factors. Nature 1994; 367: 516-7.
37. Stamatoyannopoulos JA, Goodwin A, Joyce T, Lowrey CH. NF-E2 and GATA binding motifs are required for the formation of DNase I hypersensitive site 4 of the human beta-globin locus control region. EMBO J 1995; 14: 106-16.
38. Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the kruppel family of nuclear proteins. Mol Cell Biol 1993; 13: 2776-86.
39. Bieker JJ, Southwood CM. The erythroid kruppel-like factor transactivation domain is a critical component for cell-specific inducibility of a β-globin promoter. Mol Cell Biol 1995; 15: 852-60.
40. Feng WC, Southwoods CW, Bieker JJ. Analyses of β-thalassemia mutant DNA interactions with erythroid kruppel-like factor, an erythroid cell-specifc transcription factor. J Biol Chem 1994; 269: 1-8.
41. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 1995; 375: 316-8.
42. Perkins AC, Sharpe AH, Orkin SH. Lethal β-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 1995; 375: 318-22.
43. Mouthon M-A, Bernard O, Mitjavila MT, Romeo P-H, Vainchenker W, Mathieu-Mauhul D. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 1993; 81: 647-55.
44. Bresnick EH, Felsenfeld G. Evidence that the transcription factor USF is a component of the human β-globin locus control region heteromeric protein complex. J Biol Chem 1993; 268: 18824-34.
45. Aplan PD, Nakahara K, Orkin SH, Kirsch IR. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J 1992; 11: 4073-81.
46. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 1995; 373: 432-4.
47. Valge-Archer VE, Osada H, Warren AJ, et al. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci 1994; 91: 8617-21.
48. Foroni L, Boehm T, White L, et al. The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. J Mol Biol 1992; 226: 747-61.
49. Crossley M, Merika M, Orkin SH. Self-association of the erythroid transcription factor GATA-1 mediated by its zinc finger domains. Mol Cell Biol 1995; 15: 2448-56.
50. Warren AJ, Colledge WH, Carlton MBL, Evans MJ, Smith AJH, Rabbitts TH. The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell 1994; 78: 45-57.
51. Jane SM, Nienhuis AW, Cunningham JM. Hemoglobin switching in man and chicken is mediated by a heteromeric complex between the ubiquitous transcription factor CP2 and a developmentally specific protein. EMBO J 1995; 14: 97-105.
52. Gallarda JL, Foley KP, Yang Z, Engel JD. The β-globin stage selector element factor is erythroid-specific promoter/enhancer binding protein NF-E4. Genes Dev 1989; 3: 1845-59.
53. Yang Z, Engel JD. Biochemical characterization of the developmental stage- and tissue-specific erythroid transcription factor, NF-E4. J Biol Chem 1994; 269: 10079-87.
54. Klempnauer K-H, Gonda TD, Bishop JM. Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 1982; 31: 453-63.
55. Klempnauer K-H, Arnold H, Biedenkapp H. Activation of transcription by v-myb: evidence for two different mechanisms. Genes Dev 1989; 3: 1582-9.
56. Clarke MF, Kukowska-Latallo JF, Westin E, Smith M, Prochownik EU. Constitutive expression of a c-myb cDNA blocks friend murine erythroleukemia cell differentiation. Mol Cell Biol 1988; 8: 884-92.
57. Mucenski ML, McLain K, Kier AB, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991; 65: 677-89.
58. Todokoro K, Watson RJ, Higo H, et al. Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proc Nat Acad Sci USA 1988; 85: 8900-4.
59. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994; 265: 1573-7.
60. Strubin M, Newell JW, Matthias P. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 1995; 80: 497-506.